Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,278 | 213 | 97.8% |
| Education | $95.26 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,778 | 106 | $0 (2024) |
| Janssen Biotech, Inc. | $537.66 | 27 | $0 (2024) |
| PFIZER INC. | $431.87 | 20 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $388.43 | 19 | $0 (2024) |
| Lilly USA, LLC | $362.86 | 11 | $0 (2024) |
| GENZYME CORPORATION | $270.45 | 6 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $161.41 | 6 | $0 (2024) |
| Amgen Inc. | $119.99 | 5 | $0 (2024) |
| Dermavant Sciences, Inc. | $113.33 | 5 | $0 (2024) |
| Incyte Corporation | $47.40 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,678 | 69 | ABBVIE INC. ($562.93) |
| 2023 | $1,662 | 80 | ABBVIE INC. ($451.64) |
| 2022 | $739.33 | 40 | ABBVIE INC. ($480.05) |
| 2021 | $293.27 | 26 | AbbVie Inc. ($282.89) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $32.92 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: DERMATOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $5.58 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.31 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Immunology | ||||||
| 10/15/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: DERMATOLOGY | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/08/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Immunology | ||||||
| 10/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $34.47 | General |
| Category: Immunology | ||||||
| 09/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: IMMUNOLOGY | ||||||
| 09/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $4.97 | General |
| Category: Immunology | ||||||
| 09/10/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 09/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $33.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: DERMATOLOGY | ||||||
| 08/29/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: IMMUNOLOGY | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.60 | General |
| Category: Immunology | ||||||
| 08/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.14 | General |
| Category: Immunology | ||||||
| 08/06/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 793 | 1,237 | $235,848 | $59,219 |
| 2022 | 13 | 779 | 1,307 | $255,723 | $61,561 |
| 2021 | 14 | 736 | 1,299 | $224,231 | $56,916 |
| 2020 | 13 | 698 | 1,272 | $184,477 | $41,406 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 161 | $48,300 | $13,465 | 27.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 190 | 241 | $48,200 | $13,124 | 27.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 83 | 97 | $25,705 | $6,598 | 25.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 98 | 128 | $27,008 | $4,683 | 17.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 48 | 56 | $16,128 | $4,358 | 27.0% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 19 | 20 | $16,040 | $4,268 | 26.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $11,125 | $2,702 | 24.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $12,400 | $2,541 | 20.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 18 | 18 | $5,040 | $1,595 | 31.6% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 70 | 305 | $5,795 | $1,469 | 25.4% |
| 29581 | Application of vein wound compression bandages on lower leg, ankle, and foot | Office | 2023 | 12 | 19 | $4,636 | $1,460 | 31.5% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 15 | 15 | $9,660 | $1,403 | 14.5% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 22 | 27 | $2,565 | $981.14 | 38.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 13 | $1,950 | $518.05 | 26.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 72 | $1,296 | $55.00 | 4.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 136 | 190 | $57,000 | $14,826 | 26.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 149 | 186 | $37,200 | $10,218 | 27.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 100 | 118 | $31,270 | $7,917 | 25.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 106 | 153 | $32,283 | $5,183 | 16.1% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2022 | 18 | 22 | $17,644 | $4,616 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $16,020 | $3,887 | 24.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 36 | 43 | $12,384 | $3,326 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 52 | 52 | $16,120 | $3,226 | 20.0% |
| 29581 | Application of vein wound compression bandages on lower leg, ankle, and foot | Office | 2022 | 14 | 31 | $7,564 | $2,012 | 26.6% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2022 | 17 | 20 | $12,880 | $1,812 | 14.1% |
About Craig Schultz
Craig Schultz is a Dermatology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619911559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Craig Schultz has received a total of $4,373 in payments from pharmaceutical and medical device companies, with $1,678 received in 2024. These payments were reported across 215 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($4,278).
As a Medicare-enrolled provider, Schultz has provided services to 3,006 Medicare beneficiaries, totaling 5,115 services with total Medicare billing of $219,101. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Other Specialties Nurse Practitioner, Nurse Practitioner
- Location Portland, OR
- Active Since 06/15/2006
- Last Updated 05/14/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1619911559
Products in Payments
- SKYRIZI (Biological) $1,292
- DUPIXENT (Biological) $464.00
- RINVOQ (Biological) $453.02
- TREMFYA (Drug) $443.15
- Sotyktu (Drug) $388.43
- EUCRISA (Drug) $264.49
- TALTZ (Drug) $250.82
- LITFULO (Drug) $124.83
- Otezla (Drug) $119.99
- VTAMA (Drug) $113.33
- OLUMIANT (Drug) $112.04
- REMICADE (Biological) $94.51
- OPZELURA (Drug) $47.40
- CIBINQO (Drug) $42.55
- Zoryve (Drug) $30.55
- HADLIMA (Drug) $27.61
- IDACIO (Biological) $23.15
- HUMIRA (Biological) $22.71
- BLU-U (Medical Supply) $19.70
- ILUMYA (Biological) $18.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Portland
Andrew Blauvelt, Md, MD
Dermatology — Payments: $2.6M
Eric Simpson, Md, MD
Dermatology — Payments: $2.2M
Benjamin Ehst, M.d., Ph.d, M.D., PH.D
Dermatology — Payments: $1.5M
Dr. Jason Hawkes, Md, Ms, MD, MS
Dermatology — Payments: $876,779
Dr. Omar Qutub, Md, MD
Dermatology — Payments: $73,858
Alex Ortega Loayza, Md, MD
Dermatology — Payments: $72,824